A citation-based method for searching scientific literature

Chronic central serous chorioretinopathy: photodynamic therapy.
Mehryar Taban, David S Boyer, Edgar L Thomas, Mehran Taban. Am J Ophthalmol 2004
Times Cited: 132



The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.
Felice Cardillo Piccolino, Roberta Rigault de la Longrais, Giambattista Ravera, Chiara M Eandi, Luca Ventre, Ali' Abdollahi, Marilisa Manea. Am J Ophthalmol 2005
Times Cited: 234




List of shared articles



Times cited

Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.
Evita Evangelia Christou, Panagiotis Stavrakas, Vassilios Kozobolis, Andreas Katsanos, Ilias Georgalas, Maria Stefaniotou. Graefes Arch Clin Exp Ophthalmol 2022
5

Evaluation of the choroidal vascularity index after subthreshold yellow laser treatment in the patients with chronic central serous chorioretinopathy.
Sema Tamer Kaderli, Aylin Karalezli, Ahmet Kaderli, Simay Can Taskin, Sabahattin Sul. Eye (Lond) 2022
0

Morphological integrity of the outer retinal layers and visual prognosis in chronic central serous chorioretinopathy after half-dose photodynamic therapy: a qualitative SD-OCT analysis.
Hamidu Hamisi Gobeka, Jale Mentes, Serhad Nalcaci, Zafer Oztas, Yigit Cay. Lasers Med Sci 2022
0

Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.
Sónia Torres-Costa, Susana Penas, Ana Rita Cerqueira, Elisete Brandão, Ângela Carneiro, Amândio Rocha-Sousa, Fernando Falcão-Reis. Photodiagnosis Photodyn Ther 2021
3

Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy.
Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee. PLoS One 2020
0

Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
Bo Kwon Son, Kiyoung Kim, Eung Suk Kim, Seung-Young Yu. Ophthalmologica 2019
14

Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
Sibel Demirel, Gökçen Özcan, Özge Yanık, Figen Batıoğlu, Emin Özmert. Graefes Arch Clin Exp Ophthalmol 2019
21

Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy.
Emin Özmert, Sibel Demirel, Özge Yanık, Figen Batıoğlu. J Ophthalmol 2016
39

A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
Mingwei Zhao, Feng Zhang, Youxin Chen, Hong Dai, Jinfeng Qu, Chongya Dong, Xiaoping Kang, Yuling Liu, Liu Yang, Yibin Li,[...]. JAMA Ophthalmol 2015
42

Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
Kyoko Fujita, Yutaka Imamura, Kei Shinoda, Celso Soiti Matsumoto, Yoshihiro Mizutani, Atsushi Mizota, Mitsuko Yuzawa. Retina 2014
16

Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Chun-Fu Liu, Lee-Jen Chen, Shawn H Tsai, Chi-Chun Lai, Wei-Chun Chan, Wei-Chi Wu, Nan-Kai Wang, Kuan-Jen Chen, Yih-Shiou Hwang, Yen-Po Chen,[...]. J Ocul Pharmacol Ther 2014
12

Central serous chorioretinopathy: a review of epidemiology and pathophysiology.
Gerald Liew, Godfrey Quin, Mark Gillies, Samantha Fraser-Bell. Clin Exp Ophthalmol 2013
243

Early changes in foveal thickness in eyes with central serous chorioretinopathy.
Masayuki Hata, Akio Oishi, Masataka Shimozono, Michiko Mandai, Akihiro Nishida, Yasuo Kurimoto. Retina 2013
35

Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
Helena Vasconcelos, Inês Marques, A Rita Santos, Pedro Melo, Isabel Pires, João Figueira, José Faria de Abreu, M Luz Cachulo, Rufino Silva. Graefes Arch Clin Exp Ophthalmol 2013
38

Central serous chorioretinopathy: update on pathophysiology and treatment.
Benjamin Nicholson, Jason Noble, Farzin Forooghian, Catherine Meyerle. Surv Ophthalmol 2013
371

One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.
Yasuhiro Ohkuma, Takaaki Hayashi, Tsutomu Sakai, Akira Watanabe, Hiroshi Tsuneoka. Graefes Arch Clin Exp Ophthalmol 2013
27

Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.
S H Karakus, B Basarir, E Y Pinarci, E U Kirandi, A Demirok. Eye (Lond) 2013
39

Photodynamic therapy in the treatment of persistent central serous chorioretinopathy: a two-year follow-up.
C Valmaggia, I Haueter, H Niederberger. Klin Monbl Augenheilkd 2012
7

Graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy.
George J Manayath, Venkatapathy Narendran, Saurabh Arora, Rodney J Morris, Veerappan R Saravanan, Parag K Shah. Ophthalmic Surg Lasers Imaging 2012
7

Photodynamic therapy and central serous chorioretinopathy.
Lina Siaudvytyte, Vaida Diliene, Goda Miniauskiene, Vilma Jurate Balciuniene. Med Hypothesis Discov Innov Ophthalmol 2012
9

Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Kyoko Fujita, Mitsuko Yuzawa, Ryusaburou Mori. Retina 2011
36

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
J Fernando Arevalo, Juan V Espinoza. Graefes Arch Clin Exp Ophthalmol 2011
16

Factors influencing the visual acuity of chronic central serous chorioretinopathy.
Yun Young Kim, Christina J Flaxel. Korean J Ophthalmol 2011
18


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy